Back to today’s briefing

Story perspectives

Breakthrough CRISPR-engineered Microglia Target Alzheimer’s Treatment

4/22/2025

25 4

Summary

Story summary

Researchers at UC Irvine have made a groundbreaking advancement by engineering human microglia to identify Alzheimer’s-related brain changes and release therapeutic proteins exactly where they're needed. Utilizing CRISPR technology, these microglia not only reduced inflammation but also protected neurons in mouse models, paving the way for revolutionary treatments for Alzheimer’s and other neurological disorders.

1 of 1

Story summary

Researchers at UC Irvine have made a groundbreaking advancement by engineering human microglia to identify Alzheimer’s-related brain changes and release therapeutic proteins exactly where they're needed. Utilizing CRISPR technology, these microglia not only reduced inflammation but also protected neurons in mouse models, paving the way for revolutionary treatments for Alzheimer’s and other neurological disorders.